KLK3 and pachyonychia congenita: RTOG 0534, a Phase III Trial of short-term androgen deprivation with pelvic lymph node or prostate bed only radiotherapy (SPPORT) in PC patients with a rising PSA after RP, is currently accruing (http://www.clinicaltrials.gov/ct2/show/NCT00567580/).